Aspirin (delayed release tablet)

Aspirin (delayed release tablet)
	Black Box Warning
	Adult Indications & Dosage
	Pediatric Indications & Dosage
	Contraindications
	Warnings & Precautions
	Adverse Reactions
	Drug Interactions
	Use in Specific Populations
	Administration & Monitoring
	Overdosage
	Pharmacology
	Clinical Studies
	How Supplied
	Images
	Patient Counseling Information
	Precautions with Alcohol
	Brand Names
	Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

ConditionName:

See full prescribing information for complete Boxed Warning.

ConditionName:

Content

Overview

Aspirin (delayed release tablet) is a {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition1

Dosing Information

Dosage

Condition2

Dosing Information

Dosage

Condition3

Dosing Information

Dosage

Condition4

Dosing Information

Dosage

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition1

Developed by:

Class of Recommendation:

Strength of Evidence:

Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Aspirin (delayed release tablet) in adult patients.

Non–Guideline-Supported Use

Condition1

Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aspirin (delayed release tablet) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition1

Dosing Information

Dosage

Condition2

There is limited information regarding FDA-Labeled Use of Aspirin (delayed release tablet) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition1

Developed by:

Class of Recommendation:

Strength of Evidence:

Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Aspirin (delayed release tablet) in pediatric patients.

Non–Guideline-Supported Use

Condition1

Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aspirin (delayed release tablet) in pediatric patients.

Contraindications

Condition1

Warnings

ConditionName:

See full prescribing information for complete Boxed Warning.

ConditionName:

Content

Description

Precautions

Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Aspirin (delayed release tablet) in the drug label.

Body as a Whole

Cardiovascular

Digestive

Endocrine

Hematologic and Lymphatic

Metabolic and Nutritional

Musculoskeletal

Neurologic

Respiratory

Skin and Hypersensitivy Reactions

Special Senses

Urogenital

Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Aspirin (delayed release tablet) in the drug label.

Body as a Whole

Cardiovascular

Digestive

Endocrine

Hematologic and Lymphatic

Metabolic and Nutritional

Musculoskeletal

Neurologic

Respiratory

Skin and Hypersensitivy Reactions

Special Senses

Urogenital

Miscellaneous

Drug Interactions

Drug

Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

Pregnancy Category

Pregnancy Category (AUS):

Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Aspirin (delayed release tablet) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Aspirin (delayed release tablet) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Aspirin (delayed release tablet) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Aspirin (delayed release tablet) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Aspirin (delayed release tablet) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Aspirin (delayed release tablet) in patients who are immunocompromised.

Administration and Monitoring

Administration

Oral

Intravenous

Monitoring

There is limited information regarding Monitoring of Aspirin (delayed release tablet) in the drug label.

Description

IV Compatibility

There is limited information regarding IV Compatibility of Aspirin (delayed release tablet) in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

Description

Management

Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Aspirin (delayed release tablet) in the drug label.

Pharmacology

There is limited information regarding Aspirin (delayed release tablet) Pharmacology in the drug label.

Mechanism of Action

Structure

File:Aspirin (delayed release tablet)01.png

This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Aspirin (delayed release tablet) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Aspirin (delayed release tablet) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Aspirin (delayed release tablet) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Aspirin (delayed release tablet) in the drug label.

How Supplied

Storage

There is limited information regarding Aspirin (delayed release tablet) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Aspirin (delayed release tablet) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Aspirin (delayed release tablet) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Aspirin (delayed release tablet) in the drug label.

Precautions with Alcohol

Alcohol-Aspirin (delayed release tablet) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

®^[1]

Look-Alike Drug Names

A® — B®^[2]

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

↑ Empty citation (help)
↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Aspirin (delayed release tablet)
 |Label Name=Aspirin (delayed release tablet)11.png

}}

{{#subobject:

 |Label Page=Aspirin (delayed release tablet)
 |Label Name=Aspirin (delayed release tablet)11.png

}}

Pill Images

{{#ask: Page Name::Aspirin (delayed release tablet) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }} {{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Butalbital_Aspirin_and_Caffeine_NDC_01431785.jpg
 |Drug Name=Butalbital, Aspirin and Caffeine
 |Pill Ingred=BUTALBITAL[BUTALBITAL];ASPIRIN[ASPIRIN];CAFFEINE[CAFFEINE]|+sep=;
 |Pill Imprint=Westward;785
 |Pill Dosage=325 mg
 |Pill Color=White|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=West-ward Pharmaceutical Corp
 |NDC=01431785

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Aspirin_NDC_05363086.jpg
 |Drug Name=Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=AP;121
 |Pill Dosage=81 mg
 |Pill Color=Yellow|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=8
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Rugby Laboratories Inc.
 |NDC=05363086

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Micro-Coated_Aspirin_NDC_05363305.jpg
 |Drug Name=Micro-Coated Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=TCL;011
 |Pill Dosage=325 mg
 |Pill Color=White|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=10
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Rugby Laboratories, Inc
 |NDC=05363305

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Enteric_Coated_Aspirin_NDC_05363313.jpg
 |Drug Name=Enteric Coated Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=T
 |Pill Dosage=325 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Rugby Laboratories, Inc
 |NDC=05363313

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Butalbital_Aspirin_Caffeine_and_Codeine_Phosphate_NDC_05913546.jpg
 |Drug Name=Butalbital, Aspirin, Caffeine and Codeine Phosphate
 |Pill Ingred=CODEINE PHOSPHATE[CODEINE ANHYDROUS];BUTALBITAL[BUTALBITAL];CAFFEINE[CAFFEINE];ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=WATSON;3546
 |Pill Dosage=325 mg
 |Pill Color=Blue;Yellow|+sep=;
 |Pill Shape=Capsule
 |Pill Size (mm)=22
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Watson Laboratories, Inc.
 |NDC=05913546

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Aspirin_NDC_06030024.jpg
 |Drug Name=Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=AZ013
 |Pill Dosage=81 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=8
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Qualitest Pharmaceutical, Inc.
 |NDC=06030024

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Enteric_Coated_Aspirin_NDC_06030169.jpg
 |Drug Name=Enteric Coated Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=T;A
 |Pill Dosage=325 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Qualitest Pharmaceuticals
 |NDC=06030169

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Butalbital_Aspirin_and_Caffeine_Tablets_NDC_06032548.jpg
 |Drug Name=Butalbital, Aspirin and Caffeine Tablets
 |Pill Ingred=ASPIRIN[ASPIRIN];BUTALBITAL[BUTALBITAL];CAFFEINE[CAFFEINE]|+sep=;
 |Pill Imprint=West;ward;785
 |Pill Dosage=325 mg
 |Pill Color=White|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=7
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Qualitest
 |NDC=06032548

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=aspirin_regular_strength_NDC_09042009.jpg
 |Drug Name=aspirin regular strength
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=Aspirin;A1
 |Pill Dosage=325 mg
 |Pill Color=White|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Major Pharmaceuticals
 |NDC=09042009

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Regular_Strength_Aspirin_EC_NDC_09042013.jpg
 |Drug Name=Regular Strength Aspirin EC
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=T
 |Pill Dosage=325 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Major Pharmaceuticals Inc
 |NDC=09042013

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Tri-Buffered_Aspirin_NDC_09042015.jpg
 |Drug Name=Tri-Buffered Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=44;183
 |Pill Dosage=325 mg
 |Pill Color=White|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Major Pharmaceuticals
 |NDC=09042015

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=aspirin_NDC_09044040.jpg
 |Drug Name=aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=L467
 |Pill Dosage=81 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=8
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Major Pharmaceuticals
 |NDC=09044040

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=aspirin_NDC_09046288.jpg
 |Drug Name=aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=TCL;334;UPPER;LOWER;PLAIN
 |Pill Dosage=81 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=8
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Major Pharmaceuticals
 |NDC=09046288

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Aspir_Low_NDC_09047704.jpg
 |Drug Name=Aspir Low
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=N
 |Pill Dosage=81 mg
 |Pill Color=Yellow|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=7
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Major Pharmaceuticals
 |NDC=09047704

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Low_Strength_Chewable_Aspirin_NDC_578960911.jpg
 |Drug Name=Low Strength Chewable Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=AZ;013
 |Pill Dosage=81 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=7
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Geri-Care Pharmaceutical Corp
 |NDC=578960911

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Regular_Strength_Enteric_coated_aspirin_NDC_578960921.jpg
 |Drug Name=Regular Strength Enteric coated aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=44;227
 |Pill Dosage=325 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=9
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Geri-Care Pharmaceutical Corp
 |NDC=578960921

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Regular_Strength_Aspirin_EC_NDC_675440468.jpg
 |Drug Name=Regular Strength Aspirin EC
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=T
 |Pill Dosage=325 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Aphena Pharma Solutions - Tennessee, LLC
 |NDC=675440468

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Aspirin_EC_NDC_01821061.jpg
 |Drug Name=Aspirin EC
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=N
 |Pill Dosage=81 mg
 |Pill Color=Yellow|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=7
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Goldline Laboratories, Inc.
 |NDC=01821061

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Butalbital_Aspirin_and_Caffeine_NDC_05913219.jpg
 |Drug Name=Butalbital, Aspirin, and Caffeine
 |Pill Ingred=BUTALBITAL[BUTALBITAL];ASPIRIN[ASPIRIN];CAFFEINE[CAFFEINE]|+sep=;
 |Pill Imprint=WATSON;3219
 |Pill Dosage=325 mg
 |Pill Color=Green;Yellow|+sep=;
 |Pill Shape=Capsule
 |Pill Size (mm)=22
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Watson Laboratories, Inc.
 |NDC=05913219

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Aggrenox_NDC_05970001.jpg
 |Drug Name=Aggrenox
 |Pill Ingred=aspirin[aspirin];dipyridamole[dipyridamole]|+sep=;
 |Pill Imprint=01A;
 |Pill Dosage=25 mg
 |Pill Color=Red;White|+sep=;
 |Pill Shape=Capsule
 |Pill Size (mm)=24
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Boehringer Ingelheim Pharmaceuticals, Inc.
 |NDC=05970001

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Regular_Strength_Aspirin_EC_NDC_09042011.jpg
 |Drug Name=Regular Strength Aspirin EC
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=T
 |Pill Dosage=325 mg
 |Pill Color=Orange|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Major Pharmaceuticals Inc
 |NDC=09042011

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Aspirin_NDC_508440157.jpg
 |Drug Name=Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=ASPIRIN;44157
 |Pill Dosage=325 mg
 |Pill Color=White|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=L.N.K. International, Inc.
 |NDC=508440157

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Aspirin_NDC_508440249.jpg
 |Drug Name=Aspirin
 |Pill Ingred=ASPIRIN[ASPIRIN]|+sep=;
 |Pill Imprint=ASPIRIN;44249
 |Pill Dosage=325 mg
 |Pill Color=White|+sep=;
 |Pill Shape=Round
 |Pill Size (mm)=11
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=L.N.K. International, Inc.
 |NDC=508440249

}}

{{#subobject:

 |Page Name=Aspirin (delayed release tablet)
 |Pill Name=Ascomp_with_Codeine_NDC_519910074.jpg
 |Drug Name=Ascomp with Codeine
 |Pill Ingred=Butalbital[Butalbital];Aspirin[Aspirin];Caffeine[Caffeine];Codeine Phosphate[Codeine]|+sep=;
 |Pill Imprint=B074
 |Pill Dosage=325 mg
 |Pill Color=Blue;Yellow|+sep=;
 |Pill Shape=Capsule
 |Pill Size (mm)=22
 |Pill Scoring=1
 |Pill Image=
 |Drug Author=Breckenridge Pharmaceutical, Inc.
 |NDC=519910074

}}

[1] Empty citation (help)

[www.ismp.org-2] "http://www.ismp.org". External link in |title= (help)

[1]

[2]

v t e Analgesic products (N02A, N02B)
Opioids See also: Opioids template	Alphaprodine · Anileridine · Buprenorphine · Butorphanol · Codeine · Dextromoramide · Dextropropoxyphene · Dezocine · Desomorphine · Diamorphine · Dihydrocodeine · Dihydromorphine · Fentanyl · Hydrocodone · Hydromorphone · Ketobemidone · Levorphanol · Meptazinol · Methadone · Morphine · Nalbuphine · Nicomorphine · Opium · Oxycodone · Oxymorphone · Pethidine · Pentazocine · Pethidine · Piminodine · Piritramide · Tilidine · Tramadol · Tapentadol
Salicylic acid and derivatives	Aspirin (Acetylsalicylic Acid) · Benorylate · Diflunisal · Ethenzamide · Magnesium Salicylate · Salicin · Salicylamide · Salsalate · See also: NSAIDs
Pyrazolones	Ampyrone/Aminophenazone · Metamizole · Phenazone
Cannabinoids	Cannabis · Tetrahydrocannabinol · AM404
Anilides	Paracetamol (acetaminophen) · Phenacetin · Propacetamol
Non-Salicylate Non-Steroidal Anti-Inflammatories See also: NSAIDs template	Template:Navbox subgroup
Atypical, Adjunct & Miscellaneous	Bicifadine · Clonidine · Cyclobenzaprine · Duloxetine · Flupirtine · Gabapentin · Nefopam · Orphenadrine · Trazadone · Ziconotide

v t e Non-steroidal anti-inflammatory drug (NSAID) products (primarily M01A and M02A, also N02BA)
Salicylates	Aspirin (acetylsalicylic acid) · Aloxiprin · Benorylate · Diflunisal · Ethenzamide · Magnesium salicylate · Methyl salicylate · Salsalate · Salicin · Salicylamide · Sodium salicylate
Arylalkanoic acids	Diclofenac · Aceclofenac · Acemetacin · Alclofenac · Bromfenac · Etodolac · Indometacin · Indomethacin farnesil · Nabumetone · Oxametacin · Proglumetacin · Sulindac · Tolmetin
2-Arylpropionic acids (profens)	Ibuprofen · Alminoprofen · Benoxaprofen · Carprofen · Dexibuprofen · Dexketoprofen · Fenbufen · Fenoprofen · Flunoxaprofen · Flurbiprofen · Ibuproxam · Indoprofen^† · Ketoprofen · Ketorolac · Loxoprofen · Miroprofen · Naproxen · Oxaprozin · Pirprofen · Suprofen · Tarenflurbil · Tiaprofenic acid
N-Arylanthranilic acids (fenamic acids)	Mefenamic acid · Flufenamic acid · Meclofenamic acid · Tolfenamic acid
Pyrazolidine derivatives	Phenylbutazone · Ampyrone · Azapropazone · Clofezone · Kebuzone · Metamizole^† · Mofebutazone · Oxyphenbutazone · Phenazone · Sulfinpyrazone
Oxicams	Piroxicam · Droxicam · Lornoxicam · Meloxicam · Tenoxicam
COX -2 inhibitors	Celecoxib · Deracoxib^‡ · Etoricoxib · Firocoxib^‡ · Lumiracoxib^† · Parecoxib · Rofecoxib^† · Valdecoxib^†
Sulphonanilides	Nimesulide
Topically used products	Bendazac · Diclofenac · Etofenamate · Felbinac · Flurbiprofen · Ibuprofen · Indometacin · Ketoprofen · Naproxen · Piroxicam · Suprofen
Others	Fluproquazone · COX-inhibiting nitric oxide donator
Items listed in bold indicate initially developed compounds of specific groups. ^†Withdrawn drugs. ^‡Veterinary use medications.